Table: Hisamitsu - 6-MTH group results
Oct 9 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Aug 31, 2025 Aug 31, 2024 Feb 28, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 74.94 75.46 165.00
(-0.7 pct) (+12.7 pct) (+5.8 pct)
Operating 8.13 9.01 20.00
(-9.7 pct) (+7.3 pct) (+5.8 pct)
Recurring 10.09 10.79 24.30
(-6.5 pct) (-7.3 pct) (+1.2 pct)
Net 7.02 9.10 22.00
(-22.8 pct) (+8.1 pct) (+1.1 pct)
EPS 97.00 yen 122.71 yen 303.89 yen
EPS Diluted 96.88 yen 122.55 yen
Ann Div 90.00 yen 120.00 yen
-Q2 div 60.00 yen 45.00 yen
-Q4 div 45.00 yen 60.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO